Rosaria Sancetta

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

Andrea Gallamini, Luigi Rigacci, Francesco Merli et al. · PubMed · 2006 · 294 citations

Medicine, Nuclear Medicine, Oncology +16

Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi

Luigi Rigacci, Umberto Vitolo, Luca Nassi et al. · Annals of Hematology · 2007 · 108 citations

Medicine, Oncology, Radiology +10

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis et al. · Blood · 2019 · 99 citations · Full text

Life Sciences, Genetics, Hematology +13

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso et al. · Blood Advances · 2019 · 89 citations · Full text

Medicine, Hematology, Pharmacology +11

The prognostic value of positron emission tomography performed after two courses (<scp>INTERIM‐PET</scp>) of standard therapy on treatment outcome in early stage <scp>H</scp>odgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)

Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani et al. · American Journal of Hematology · 2015 · 50 citations · Full text

Medicine, Hematology, Oncology +17